SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
NanoVibronix, Inc. (NAOV) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 40/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — NAOV
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio2.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-13.73
Book Value / Share$0.00
Revenue / Share$0.95
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$-16.31 |
$147K |
$-2.88M |
-1961.9% |
| 2016 |
$-12.37 |
$229K |
$-2.83M |
-1236.2% |
| 2017 |
$-20.00 |
$239K |
$-4.97M |
-2077.4% |
| 2018 |
$-12.88 |
$318K |
$-4.15M |
-1306.3% |
| 2019 |
$-16.70 |
$530K |
$-5.79M |
-1093.2% |
| 2020 |
$-8.40 |
$623K |
$-4.33M |
-694.4% |
| 2021 |
$-11.35 |
$1.7M |
$-14.28M |
-842.6% |
| 2022 |
$-3.84 |
$752K |
$-5.45M |
-724.5% |
| 2023 |
$-2.12 |
$2.28M |
$-3.71M |
-162.5% |
| 2024 |
$-13.73 |
$2.56M |
$-3.71M |
-144.8% |
